| 发明名称 |
NITROGENATED HETEROCYCLIC COMPOUND |
| 摘要 |
<p>The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1):
wherein each symbol is as described in the specification, or a salt thereof.</p> |
| 申请公布号 |
SG11201406552U(A) |
申请公布日期 |
2014.11.27 |
| 申请号 |
SG11201406552U |
申请日期 |
2013.04.24 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
MIKAMI, SATOSHI;NAKAMURA, SHINJI;ASHIZAWA, TOMOKO;SASAKI, SHIGEKAZU;TANIGUCHI, TAKAHIKO;NOMURA, IZUMI;KAWASAKI, MASANORI |
| 分类号 |
C07D471/04;A61K31/4985;A61P25/18;A61P43/00 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
